TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.

Shiao-Pei Weathers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.